The Lancet Haematology
Công bố khoa học tiêu biểu
* Dữ liệu chỉ mang tính chất tham khảo
Sắp xếp:
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
The Lancet Haematology - Tập 9 - Trang e262-e275 - 2022
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
The Lancet Haematology - Tập 6 - Trang e359-e365 - 2019
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
The Lancet Haematology - Tập 6 - Trang e132-e143 - 2019
Comparison of international guideline recommendations for the diagnosis of pulmonary embolism
The Lancet Haematology - Tập 10 - Trang e922-e935 - 2023
Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma
The Lancet Haematology - Tập 10 - Trang e213-e224 - 2023
Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis
The Lancet Haematology - Tập 8 - Trang e503-e512 - 2021
Analysis of an algorithm incorporating limited and whole-leg assessment of the deep venous system in symptomatic outpatients with suspected deep-vein thrombosis (PALLADIO): a prospective, multicentre, cohort study
The Lancet Haematology - Tập 2 - Trang e474-e480 - 2015
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
The Lancet Haematology - Tập 6 - Trang e254-e265 - 2019
Epidemiological patterns of leukaemia in 184 countries: a population-based study
The Lancet Haematology - Tập 5 - Trang e14-e24 - 2018
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial
The Lancet Haematology - Tập 8 - Trang e879-e890 - 2021
Tổng số: 263
- 1
- 2
- 3
- 4
- 5
- 6
- 10